Evidence map›Paper›PMID 27822455›Full record

ArticleFrontiers in oncology2016

Burden of Cancers Attributable to Infectious Agents in Nigeria: 2012-2014.

Michael Odutola, Elima E Jedy-Agba, Eileen O Dareng, Emmanuel Aja Oga, Festus Igbinoba, Theresa Otu, Emmanuel Ezeome, Ramatu Hassan, Clement A Adebamowo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 9 institutions in 3 countries.

Michael OdutolaInstitute of Human Virology , Abuja , Nigeria.
Elima E Jedy-AgbaDepartment of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine , London , UK.
Eileen O DarengDepartment of Public Health and Primary Care, Center for Cancer Genetic Epidemiology, University of Cambridge , Cambridge , UK.
Emmanuel Aja OgaBattelle Memorial Institute , Baltimore, MD , USA.
Festus IgbinobaNational Hospital Abuja , Abuja , Nigeria.
Theresa OtuUniversity of Abuja Teaching Hospital Gwagwalada , Gwagwalada , Nigeria.
Emmanuel EzeomeUniversity of Nigeria Teaching Hospital Enugu , Enugu , Nigeria.
Ramatu HassanFederal Ministry of Health , Abuja , Nigeria.
Clement A AdebamowoInstitute of Human Virology, Abuja, Nigeria; Department of Epidemiology and Public Health, Marlene and Stewart Greenebaum Comprehensive Cancer Center, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
Battelle · USFederal Ministry of Health · NGInstitute of Human Virology · NGLondon School of Hygiene & Tropical Medicine · GBNational Hospital Abuja · NGUniversity of Abuja Teaching Hospital · NGUniversity of Cambridge · GBUniversity of Maryland, Baltimore · USUniversity of Nigeria Teaching Hospital · NG

Funding

African Collaborative Center for Microbiome and Genomics Research (ACCME)U54HG006947 · NHGRI · INSTITUTE OF HUMAN VIROLOGY · PI ADEBAMOWO, CLEMENT ADEBAYO · 2013 to 2018
$5.7M
Capacity Development for Research into AIDS Associated malignancies (CADRE)D43CA153792 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI ADEBAMOWO, CLEMENT ADEBAYO · 2010 to 2013
$1.8M
NCI NIH HHS D43 CA153792NHGRI NIH HHS U54 HG006947
6 · The paper itself

Abstract

introductionInfections by certain viruses, bacteria, and parasites have been identified as risk factors for some cancers. In Nigeria, like many other developing countries, infections remain a leading cause of morbidity and mortality. While there are data on the incidence of different cancers in Nigeria, there has been no study of cancers attributable to infections. This study was carried out to determine the burden of cancers attributable to infections using data from two population-based cancer registries (PBCRs) in Nigeria.

methodsWe obtained data on cancers associated with EBV, human papillomavirus (HPV), hepatitis B and C, HIV, HHV8,

resultsThe PBCRs reported 4,336 incident cancer cases [age standardized incidence rate (ASR) 113.9 per 100,000] from 2012 to 2014, of which 1,627 (37.5%) were in males and 2,709 (62.5%) were in females. Some 1,030 (23.8%) of these cancers were associated with infections (ASR 44.4 per 100,000), while 951 (22.0%) were attributable to infections (ASR 41.6 per 100,000). Cancers of the cervix (

conclusionOur results suggest that 23.8% of incident cancer cases in this population were associated with infections, while 22.0% were attributable to infections. The infections attributable cancers are potentially preventable with strategies, such as vaccination, risk factor modification, or anti-infective treatment.

Indexed as

cancer registrycancersinfectious agentsNigeriapopulation-attributable fraction

Identifiers

PMID27822455
PMCPMC5075533
OpenAlexW2533855829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.